LTR Pharma (ASX:LTP) Net Margin %: -7,785.14% (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.56
! 1 Warning Sign
View Full Analysis

What is LTR Pharma Net Margin %?

LTR Pharma ASX:LTP -4.27% 15 Net Margin % is -7,785.14% as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 946 Biotechnology companies, LTR Pharma ranks worse than 90.7% on this metric.

Net margin is calculated as Net Income divided by its Revenue. LTR Pharma's Net Income for the six months ended in Dec. 2025 was A$-5.76 Mil. LTR Pharma's Revenue for the six months ended in Dec. 2025 was A$0.07 Mil. Therefore, LTR Pharma's net margin for the quarter that ended in Dec. 2025 was -7,785.14%.

The historical rank and industry rank for LTR Pharma's Net Margin % or its related term are showing as below:

ASX:LTP' s Net Margin % Range Over the Past 10 Years
Min: -5700.64   Med: -3831.51   Max: -3831.51
Current: -5700.64

ASX:LTP's Net Margin % is ranked worse than
90.7% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs ASX:LTP: -5700.64

LTR Pharma  (ASX:LTP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

LTR Pharma Net Margin % Related Terms

LTR Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Net Margin % Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Net Margin %
0.00 0.00 0.00 0.00 -3,831.51

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial 0.00 0.00 -3,817.46 -3,842.17 -7,785.14

ASX:LTP vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, LTR Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Net Margin % falls into.


ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

LTR Pharma's Net Margin for the fiscal year that ended in Jun. 2025 is calculated as

Net Margin=Net Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-5.594/0.146
=-3,831.51 %

LTR Pharma's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-5.761/0.074
=-7,785.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -7,785.14% mean?
LTR Pharma (ASX:LTP) has a Net Margin % of -7,785.14% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on LTR Pharma and its competitors. According to the industry distribution chart, LTR Pharma ranks #858 out of 946 companies in the Biotechnology industry, placing it in the top 90.7%.
Is LTR Pharma's Net Margin % too high?
LTR Pharma's current Net Margin % is -7,785.14%. Based on the distribution chart, LTR Pharma ranks #858 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, LTR Pharma ranks #858 out of 946 companies for Net Margin %. This places LTR Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on LTR Pharma and its competitors. LTR Pharma's current Net Margin % is -7,785.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Net Margin % of -7,785.14%. The current Net Margin % is -7,785.14%. LTR Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Net Margin % is -7,785.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.56
Price